vimarsana.com
Home
Live Updates
EyeBio Announces Expansion of Series A to $130 Million, Adva
EyeBio Announces Expansion of Series A to $130 Million, Adva
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
NEW YORK & LONDON--(BUSINESS WIRE)--Nov 14, 2023--
Related Keywords
United Kingdom ,
London ,
City Of ,
United States ,
Bernard Davitian ,
Matt Pera ,
Christine Brennan ,
David Guyer ,
Tony Adamis ,
Eyebiotech Limited Eyebio ,
Sv Health Investors ,
Ventures Fund ,
Bain Capital Life Sciences ,
Merck Co Inc ,
Eyebio Eyebiotech ,
Omega Funds ,
Vertex Ventures ,
Jeito Capital ,
Samsara Biocapital ,
Managing Director ,
Chief Executive Officer ,
Chief Scientific Officer ,
Anti Permeability Mechanism ,
Age Related Ocular Neovascularization Evaluation ,
Eyebiotech Limited ,
Business Wire ,
Region ,